One conference topic regarded alternative listing strategies, such as the AIM London Stock Exchange. I have written a series on this subject and covered its merits in depth (see AIM under the Categories section). The plus side is their regulatory requirements are rather lax compared to the US Securities and Exchange Commission and Sarbanes Oxley compliance. However, the biggest problem with companies listed on AIM is their limited US exposure and apparent liquidity issues. US investors have shown very little interest in AIM-listed companies in the past, and I doubt that will change in the near future. If your company is listed on AIM and a second round of funding is necessary, plan on spending a substantial amount of time in Europe trying to raise capital. Very few US-based funds will entertain an investment on an AIM-listed company.
Did you like this article?
's
